Substance and Non Substance Related Addiction Disorders: Diagnosis and Treatment


by

Subhash C. Bhatia, Frederick Petty, Teri Gabel

DOI: 10.2174/97816810834381170101
eISBN: 978-1-68108-343-8, 2017
ISBN: 978-1-68108-344-5



Recommend this eBook to your Library

Indexed in: EBSCO.

Substance and Non substance Related Addiction Disorders: Diagnosis and Treatment ...[view complete introduction]

Table of Contents

Foreword

- Pp. i

Frederick Petty

Download Free

Preface

- Pp. ii-iii (2)

Subhash C. Bhatia, Frederick Petty and Teri Gabel

Download Free

List of Contributors

- Pp. iv

Subhash C. Bhatia, Frederick Petty and Teri Gabel

Download Free

Neurobiology and Psycho-Social Basis for Addiction and Related Disorders

- Pp. 3-9 (7)

Subhash C. Bhatia

View Abstract Purchase Chapter

Urine Drug Screening (UDS) in the Management of Substance Use Disorders

- Pp. 10-20 (11)

Teri Gabel

View Abstract Purchase Chapter

Genetics of Addiction

- Pp. 21-25 (5)

Imad Alsakaf and Subhash C. Bhatia

View Abstract Purchase Chapter

Dual Diagnosis

- Pp. 26-36 (11)

R. Dario Pulido

View Abstract Purchase Chapter

Pharmacologic Treatment for Psychiatric Disorders Associated with Substance Use Disorders: An Overview

- Pp. 37-57 (21)

Teri Gabel

View Abstract Purchase Chapter

Motivational Interviewing

- Pp. 58-65 (8)

Imad Alsakaf, Subhash C. Bhatia and Shashi K. Bhatia

View Abstract Purchase Chapter

Alcohol Use Disorders

- Pp. 66-90 (25)

Teri Gabel and Sidney Kauzlarich

View Abstract Purchase Chapter

Anabolic-Androgenic Steroids (AAS) Related Disorders

- Pp. 91-98 (8)

Aly Hassan, Subhash C. Bhatia and Shashi K. Bhatia

View Abstract Purchase Chapter

Caffeine Related Use Disorder

- Pp. 99-108 (10)

Subhash C. Bhatia, Venkata Kolli, Shashi K. Bhatia and Usha Kanthety

View Abstract Purchase Chapter

Cannabis and Cannabinoid Use Disorders

- Pp. 109-120 (12)

Subhash C. Bhatia, Shashi K. Bhatia, Venkata Kolli and Jayakrishna Madabushi

View Abstract Purchase Chapter

Ecstasy Substance Use Disorder

- Pp. 121-127 (7)

Subhash C. Bhatia and Aly Hassan

View Abstract Purchase Chapter

Hallucinogen-LSD Use Disorder

- Pp. 128-135 (8)

Subhash C. Bhatia and Aly Hassan

View Abstract Purchase Chapter

Inhalant Use Disorders

- Pp. 136-143 (8)

Aly Hassan, Subhash C. Bhatia and Shashi K. Bhatia

View Abstract Purchase Chapter

Opioid Use and Addictive Disorder

- Pp. 144-167 (24)

Teri Gabel, Imad Alsakaf and James Meyer

View Abstract Purchase Chapter

Phencyclidine (PCP) Use Disorder

- Pp. 168-174 (7)

Subhash C. Bhatia and Aly Hassan

View Abstract Purchase Chapter

Sedative, Hypnotic or Anxiolytic-Related Disorders

- Pp. 175-187 (13)

Subhash C. Bhatia, Shashi K. Bhatia, Venkata Kolli and Jaya krishna Madabushi

View Abstract Purchase Chapter

Stimulant Use and Addictive Disorder: Amphetamine, Cocaine and Other Stimulants

- Pp. 188-202 (15)

Prasad R. Padala and Subhash C. Bhatia

View Abstract Purchase Chapter

Tobacco Use Disorders

- Pp. 203-215 (13)

Frederick Petty, James Meyer and Vidhyalakshmi Selvaraj

View Abstract Purchase Chapter

Non-Substance-Related Addictive Disorders

- Pp. 216-226 (11)

Subhash C. Bhatia and Shashi K. Bhatia

View Abstract Purchase Chapter

Cognitive-Behavioral Therapy and Other Psychosocial Interventions for Substance Use Disorders

- Pp. 227-242 (16)

Aly Hassan, Shashi K. Bhatia and Subhash C. Bhatia

View Abstract Purchase Chapter

Subject Index

- Pp. 243-253 (11)

Subhash C. Bhatia, Frederick Petty and Teri Gabel

Download Free

Foreword

About one person in three has a problem with potentially hazardous drug or alcohol use which often goes unrecognized. Excessive or hazardous use of drugs, including tobacco, and of alcohol, can have very negative biological, psychological and socio-economic consequences from the direct effect of the substances. In social realm addictive behaviors take a toll on relationships with friends and family. Also often harm can occur to the patient by failure to comply with medical or psychosocial treatment for abstinence or unsupervised withdrawal or through drug interactions. Thus, every practitioner should have knowledge regarding diagnosis and treatment of common substance use disorders.

The authors share with the readers wealth of information based on their experience about diagnosis and management of common substances of abuse as well as neurobiological underpinning of these disorders. Each chapter in section II features discussion of diagnosis, and approaches to treatment and highlights cases with approaches to the patient delineated.

The practitioners should find this volume useful, helpful, and interesting in helping to provide optimal health care to his or her patients.

Frederick Petty
Department of Psychiatry
Creighton University
VA Nebraska Western Iowa Health Care System
Orlando VA Medical Center
Orlando, Florida
USA


Preface

Substance use disorders are amongst the major causes of disease burden around the globe. In a World Drug Report by the United Nations Office on Drug and Crime it is estimated that 210 million individuals have used illicit drugs at least once and that these drugs are related to about 200,000 deaths. The economic burden of substance use disorders in the USA alone from health care costs, lost productivity, crime, incarceration and drug enforcement is estimated to be $524 billion.

Addiction is a brain disease where a person uses a drug compulsively despite negative consequences and drug use in turn causes persistent changes in the brain circuits which perpetuates its use. In predisposed individual’s addiction starts during adolescent years. Fortunately addictions are preventable through public awareness and education and are treatable through contemporary medications, individual, group or family therapy as a well as self-help groups. Biopsychosocial intervention can mitigate life time suffering of the patient, family, and friends. Treatment also improves the quality of their lives. Moreover it can prevent tragic loss of life as well . Extended abstinence predicts long-term recovery. Drug addiction is a chronic disease and its relapse rate is comparable to hypertension, diabetes or asthma.

Recently one notable development has been publication of DSM-5 . Our publication provides information on the diagnosis of the additive disorders consistent with this new version of DSM.

The book is titled Substance and Non Substance Related Addiction Disorders: Diagnosis and Treatment and is divided in to three sections.

  • Section I addresses basic general topics related to scientific underpinnings of addictive disorders including the neurobiology and addiction neural reward pathways, genetics and psychosocial basis of addictions; urine drug screens in diagnosis and management of substance use disorders, co-occurring psychiatric and substance use disorders and pharmacological treatment of comorbid psychiatric disorders and motivational interviewing. Each chapter has key learning points, references, a patient education hand out .
  • Section II provides updated information about individual drug related addictive disorder. Each chapter in addition to key learning points and a patient education handout, describes a case vignette and its discussion related to specific drug, its diagnosis, medical and biopsychosocial interventions. In addition these chapters include neurobiology, epidemiology summary and updated references with resources for more information.
  • Section III presents information about non-substance related addiction disorders, a vignette and its discussion, diagnosis and interdisciplinary treatment strategies. The chapter in this section is primarily devoted to gambling addiction; other non-substance related addictions are also mentioned.

This book is by multiple authors with experience in addictions and is designed to meet the clinical practice needs of internists, family physicians, nurse practitioners, physician assistants, addiction therapists, psychiatry and primary care residents, graduate students and other health care professionals interested in the care of patients with substance use and addiction disorders. A concise format for each chapter is used to maintain its user friendliness for quick review.

Subhash C. Bhatia
Department of Psychiatry
Mental Health and Behavioral Sciences
Creighton University; Department VA Nebraska- Western
Iowa Health Care System , Omaha, NE, USA
&
Frederick Petty
Department of Psychiatry
Creighton University
VA Nebraska Western Iowa Health Care System
Orlando VA Medical Center
Orlando, Florida
USA
&
Teri Gabel
VA Nebraska Western Iowa Health Care System
Clinical Pharmacy Specialist - Mental Health
Department of Psychiatry
University of Nebraska College of Medicine, Omaha NE 68198
Drug Therapy Consultants
Omaha NE USA

List of Contributors

Editor(s):
Subhash C. Bhatia
Department of Psychiatry
Mental Health and Behavioral Sciences
Creighton University; Department VA Nebraska- Western
Iowa Health Care System
Omaha
NE
USA


Frederick Petty
Department of Psychiatry
Creighton University
VA Nebraska Western Iowa Health Care System
Orlando VA Medical Center
Orlando
Florida
USA


Teri Gabel
VA Nebraska Western Iowa Health Care System
Clinical Pharmacy Specialist - Mental Health
Department of Psychiatry
University of Nebraska College of Medicine, Omaha NE 68198
Drug Therapy Consultants
Omaha
NE
USA




Contributor(s):
Aly Hassan
Phoenix VA Health Care System, Department of Psychiatry
University of Arizona, Phoenix College of Medicine
Gilbert VA Clinic, 3285 S Val Vista Drive
Gilbert, AZ 85925
USA


Frederick Petty
Orlando VA Medical Center
Orlando, Florida
USA
/
Orange City Community Based Outpatient Clinic
2583 South Volusia Ave #300
Orange City, Florida 32763
USA


Imad Alsakaf
Creighton University School of Medicine
3528 Dodge Street
Omaha
NE 68131
USA


James Meyer
Inroads to Recovery
2808 N 75th ST
Omaha, NE 68134
USA


Jayakrishna S. Madabushi
Baptist Health System
517, Crowne Woods Drive
Birmingham, AL 35244
USA


Prasad R. Padala
Clinical, VISN 16 Geriatric Research Education and Clinical Center (GRECC)
Deaprtment of Psychiatry and Geriatrics, UAMS
2200 Fort Roots Drive, North Little Rock
AR 72114
USA


R. Dario Pulido
Mental Health and Behavioral Sciences
Department VA Nebraska-Western Iowa Health Care System
4101 Woolworth Ave.
Omaha, NE 68105
USA


Shashi K. Bhatia
Departments of Psychiatry and Pediatrics
Division of Child and Adolescent Psychiatry
Creighton University
3528 Dodge, Omaha NE 68131
USA


Sidney Kauzlarich
Douglas County Community Mental Health Center
4102 Woolworth Ave
Omaha, NE 68105
USA


Subhash C. Bhatia
Department of Psychiatry
Mental Health and Behavioral Sciences
Creighton University; Department VA Nebraska- Western Iowa Health Care System 4101 Woolworth Ave
Omaha, NE 68105
USA


Teri Gabel
VA Nebraska Western Iowa Health Care System
Clinical Pharmacy Specialist - Mental Health, Omaha
NE 68105; Department of Psychiatry, University Of Nebraska College of Medicine
Omaha, NE 68198
USA
/
Drug Therapy Consultants
PC 5116 N 116 St
Omaha, NE 68164
USA


Usha Kanthety
Staff Physician
CHI, 1721
Colfax St
Schuyler, NE 68661
USA


Venkata Kolli
Child and Adolescent Fellowship Training Program
Department of Psychiatry, Creighton University School of Medicine
3528 Dodge Street Omaha, NE 68131
USA


Vidhyalakshmi Selvaraj
Department of Psychiatry
Creighton University
3528 Dodge, Omaha, NE 68131
USA




Advertisement

2nd International Conference on Counseling Psychology24th International Conference on Psychiatry & Psychosomatic Medicine


Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science